{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:16:06Z","timestamp":1762542966425,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00541","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T13:20:12Z","timestamp":1542979212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia"],"prefix":"10.3389","volume":"8","author":[{"given":"Dina","family":"ElHarouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesreen","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seham","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Adwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cam4.645","article-title":"Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)","volume":"5","author":"Padhye","year":"2016","journal-title":"Cancer Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MPH.0000000000000039","article-title":"Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group","volume":"36","author":"Hyakuna","year":"2014","journal-title":"J Pediatr Hematol Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","article-title":"Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia","volume":"117","author":"Kawedia","year":"2011","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/nar\/30.1.163","article-title":"PharmGKB: the pharmacogenetics knowledge base","volume":"30","author":"Hewett","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.autrev.2009.02.009","article-title":"The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis","volume":"8","author":"Smolders","year":"2009","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/or.11.1.9","article-title":"Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil","volume":"11","author":"Tahara","year":"2004","journal-title":"Oncol Rep."},{"key":"B8","first-page":"4165","article-title":"Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer","volume":"9","author":"Hu","year":"2003","journal-title":"Clin Cancer Res."},{"key":"B9","first-page":"1381","article-title":"Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene","volume":"9","author":"Ulrich","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct Funct."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1359\/jbmr.1997.12.7.1043","article-title":"The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women","volume":"12","author":"Harris","year":"1997","journal-title":"J Bone Miner Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2407-8-50","article-title":"ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study","volume":"8","author":"Huang","year":"2008","journal-title":"BMC Cancer"},{"key":"B13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/B978-0-12-415853-5.00025-X","volume-title":"Osteoporosis.","author":"Uitterlinden","year":"2013"},{"key":"B14","first-page":"16","article-title":"Identifying genetic risk factors for osteoporosis","volume":"6","author":"Uitterlinden","year":"2006","journal-title":"J Musculoskeletal Neuronal Interact."},{"key":"B15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.steroids.2013.01.004","article-title":"Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis","volume":"78","author":"Gong","year":"2013","journal-title":"Steroids"},{"key":"B16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan","year":"2002","journal-title":"Semin Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1124\/mol.60.6.1399","article-title":"Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3","volume":"60","author":"Thummel","year":"2001","journal-title":"Mol Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mgene.2016.03.008","article-title":"Vitamin D receptor gene polymorphism in Egyptian pediatric acute lymphoblastic leukemia correlation with BMD","volume":"9","author":"Tantawy","year":"2016","journal-title":"Meta Gene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1359\/jbmr.1999.14.5.740","article-title":"Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children","volume":"14","author":"Ames","year":"1999","journal-title":"J Bone Miner Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1359\/JBMR.050114","article-title":"Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty","volume":"20","author":"Abrams","year":"2005","journal-title":"J Bone Miner Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","article-title":"Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia","volume":"22","author":"Relling","year":"2004","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-2003-45496","article-title":"Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis","volume":"215","author":"Bernbeck","year":"2003","journal-title":"Klin Padiatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10776-003-0646-7","article-title":"Genetic analysis of steroid-induced osteonecrosis of the femoral head","volume":"8","author":"Asano","year":"2003","journal-title":"J Orthop Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.tpj.6500224","article-title":"Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia","volume":"4","author":"Krajinovic","year":"2004","journal-title":"Pharmacogenomics J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","article-title":"Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia","volume":"126","author":"Karol","year":"2015","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1182\/blood-2007-11-123885","article-title":"A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"111","author":"French","year":"2008","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00541\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T13:20:14Z","timestamp":1542979214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00541\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":26,"alternative-id":["10.3389\/fonc.2018.00541"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00541","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"article-number":"541"}}